WE ARE CREATING THE FUTURE OF HEALTH DISPENDIX provides premium liquid handling technology to scientists and lab technicians around the world, and is creating the future of medicine. Liquid handling technology enables new discoveries in areas such as drug development, diagnostics and synthetic biology. We believe that technological advances and science are made for each other. Good technology simplifies science. DISPENDIX GmbH, the premier provider of noncontact liquid handling solutions in the nano to microliter range, started out in 2016 as a spin-off from the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart, Germany. In 2018, DISPENDIX joined the world’s leading bio convergence company BICO, which now encompasses 900+ colleagues and 11 companies, offering a portfolio of technologies, products and services to create the future of health. Part of that portfolio is DISPENDIX’s award winning patented and widely recognized technology, the I.DOT (Immediate Drop-on-demand Technology), which brings intuitive automation, precision and speed to every lab, allowing scientists to optimize liquid handling workflows and accelerate their research in a range of applications.
Looking for a particular DISPENDIX employee's phone or email?
The DISPENDIX annual revenue was $16.6 million in 2026.
Petros Apostolopoulos is the CEO of DISPENDIX.
53 people are employed at DISPENDIX.
DISPENDIX is based in Stuttgart, Baden-Württemberg.
The NAICS codes for DISPENDIX are [541713, 54, 5417, 54171, 541].
The SIC codes for DISPENDIX are [873, 87].